On the Record · Seagen

Seagen acquisitions, on the record

The businesses Seagen bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

Business	Deal	When	Value
Cascadian Therapeutics, Inc. Word for word“In March 2018, we acquired Cascadian Therapeutics, Inc., or Cascadian, for a total purchase price of approximately $614.1 million.” 10-K for 2020	acquisition	March 2018	approximately $614.1 million
RemeGen Word for word“Under the terms of the agreement, we obtained exclusive license rights to disitamab vedotin for global development and commercialization outside of RemeGen’s territory for an upfront payment of $ 200.0 million.” 10-K for 2021	acquisition	—	$ 200.0 million
Array BioPharma, Inc. Word for word“We are a party to a license agreement with Array, which was acquired by Pfizer in July 2019.” 10-K for 2022	acquisition	July 2019	—

As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year ended	Cash paid for acquisitions (net of cash acquired)
2016-12-31	$0
2017-12-31	$0
2018-12-31	$598.2 million
2019-12-31	$0
2020-12-31	$0

Deal filings since 2016

2023-12-14 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2023-03-13 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2021-09-21 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2021-08-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2021-07-15 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2021-06-25 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-09-14 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-04-17 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-03-09 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2018-01-31 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-10-30 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-05-05 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-02-16 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2016-12-27 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement

Read from Seagen’s annual reports (10-K for 2022, 10-K for 2021, 10-K for 2020) and the financial data it files with the SEC, as of 2023-02-15. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.